Evidence map›Paper›PMID 38864888›Full record

ArticleDiabetologia2024

Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.

Alison D McNeilly, Jennifer R Gallagher, Mark L Evans, Bastiaan E de Galan, Ulrik Pedersen-Bjergaard, Bernard Thorens, Albena T Dinkova-Kostova, Jeffrey-T Huang, Michael L J Ashford, Rory J McCrimmon and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Alison D McNeillyDivision of Systems Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Jennifer R GallagherDivision of Systems Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Mark L EvansWellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Bastiaan E de GalanRadboud University Medical Center, Nijmegen, the Netherlands.
Ulrik Pedersen-BjergaardNordsjællands Hospital Hillerød, University of Copenhagen, Hillerød, Denmark.
Bernard ThorensFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Albena T Dinkova-KostovaDivision of Cancer Research, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Jeffrey-T HuangDivision of Systems Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Michael L J AshfordDivision of Systems Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
Rory J McCrimmonDivision of Systems Medicine, School of Medicine, Ninewells Hospital and Medical School, Dundee, UK. r.mccrimmon@dundee.ac.uk.
Hypo-RESOLVE Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38864888
PMCPMC11343922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.